VICO
Vicore Pharma Holding AB
European company
Healthcare
Biotechnology
Bid
-
Ask
-
Last Traded
-
Chg
-
-
XSTO
-
Updated: -
Research
News & analysis
Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Company Profile
Vicore Pharma Holding AB is a drug development company. The company's through is a subsidiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin system. Its drug candidate, C21, is the first small molecule compound in its class.Vicore Pharma Holding AB is a drug development company. The company's through is subsdiary is developing a new type of pharmaceutical compound, known as AT2R agonists, to stimulate the AT2 receptor within the Renin-Angiotensin systemet.
OMX:VICO
SE0007577895
SEK
Loading Comparison
Latest VICO News